Lista de obras - Tahereh Taheri - Dominio Público Uruguay

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.

artículo científico publicado en 2013

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

artículo científico publicado en 2001

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

artículo científico publicado en 2016

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

artículo científico

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.

artículo científico publicado en 2017

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening

artículo científico publicado en 2016

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis ⬇️

artículo científico publicado el 18 de abril de 2013

Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.

artículo científico publicado en 2015

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

artículo científico publicado en 2015

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

artículo científico publicado en 2011

Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model

artículo científico publicado en 2016

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

artículo científico publicado en 2014

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

artículo científico publicado en 2014

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

artículo científico publicado en 2003

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

artículo científico publicado en 2010

Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity

artículo científico publicado en 2015

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

artículo científico publicado en 2004

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

artículo científico publicado en 2004

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

artículo científico publicado en 2014

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.

artículo científico publicado en 2015

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

scientific article published on 03 January 2020

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice

artículo científico publicado en 2007

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients

artículo científico publicado en 2007

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity

artículo científico publicado en 2010

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model

artículo científico publicado en 2015

Leishmania-based expression systems.

artículo científico publicado en 2016

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis

artículo científico publicado en 2014

PUF Proteins: Cellular Functions and Potential Applications.

artículo científico publicado en 2016

Post-Genomics and Vaccine Improvement for Leishmania

artículo científico publicado en 2016

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

artículo científico publicado en 2005

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

artículo científico publicado en 2012

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

artículo científico publicado en 2009

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation

artículo científico publicado en 2002

Retracted: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

artículo científico publicado en 2015

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.

artículo científico publicado en 2016

The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica

artículo científico publicado en 2020

Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis

artículo científico publicado en 2004

Lista de obras de Tahereh Taheri

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis ⬇️

Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model

Leishmania-based expression systems.

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis

PUF Proteins: Cellular Functions and Potential Applications.

Post-Genomics and Vaccine Improvement for Leishmania

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation

Retracted: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.

The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica

Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis